In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Medicus Pharma Ltd (NASDAQ: MDCX) was $2.05 for the day, up 3.54% from the previous closing price of $1.98. In other words, the price has increased by $3.54 from its previous closing price. On the day, 0.14 million shares were traded. MDCX stock price reached its highest trading level at $2.05 during the session, while it also had its lowest trading level at $1.98.
Ratios:
Our analysis of MDCX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.92 and its Current Ratio is at 0.92.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 20 ’25 when VELOCITY FUND PARTNERS, LP sold 75,000 shares for $7.72 per share. The transaction valued at 578,940 led to the insider holds 3,248,741 shares of the business.
VELOCITY FUND PARTNERS, LP bought 118,000 shares of MDCX for $23,067,500 on May 20 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDCX now has a Market Capitalization of 45159744 and an Enterprise Value of 43654424.
Stock Price History:
The Beta on a monthly basis for MDCX is -2.56, which has changed by -0.26557863 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, MDCX has reached a high of $8.94, while it has fallen to a 52-week low of $1.79. The 50-Day Moving Average of the stock is -13.87%, while the 200-Day Moving Average is calculated to be -33.63%.
Shares Statistics:
MDCX traded an average of 344.30K shares per day over the past three months and 328710 shares per day over the past ten days. A total of 20.97M shares are outstanding, with a floating share count of 7.58M. Insiders hold about 35.84% of the company’s shares, while institutions hold 25.89% stake in the company. Shares short for MDCX as of 1763078400 were 330975 with a Short Ratio of 0.96, compared to 1760486400 on 253332. Therefore, it implies a Short% of Shares Outstanding of 330975 and a Short% of Float of 2.11.
Earnings Estimates
. The current rating of Medicus Pharma Ltd (MDCX) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.38 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.42 and -$1.69 for the fiscal current year, implying an average EPS of -$1.55. EPS for the following year is -$1.53, with 2.0 analysts recommending between -$1.31 and -$1.75.
